N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition

Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?

(2014) Andrew Shaw et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors

(2013) Qian Yong et al.   Cardiovascular Diabetology

Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants

(2013) Yan-Jun Xu et al.   HEART FAILURE REVIEWS

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII

(2013) Min Luo et al.   JOURNAL OF CLINICAL INVESTIGATION

Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare

(2012) Jordi L Tremoleda et al.   EJNMMI Research

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

(2011) David R. Whiting et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

ROS Signaling by NOX4 Drives Fibroblast-to-Myofibroblast Differentiation in the Diseased Prostatic Stroma

(2011) Natalie Sampson et al.   MOLECULAR ENDOCRINOLOGY

Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy

(2009) Mohanraj Rajesh et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI

(2008) Jianfeng Du et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY